Gustavo is a seasoned biopharmaceutical executive who joined Amcyte Pharma in 2020. For 12 years prior, he was at AGC Biologics (former CMC Biologics), where he most recently served as Chief Executive Officer. From 1994 to 2008, Dr. Mahler held senior management positions at Bayer Healthcare in US, Europe and Latin America. He currently is venture partner at Dynamk Capital and serves on the board of directors for AGC Biologics, Absci and Life Science Washington. Dr. Mahler received a PhD in Biochemistry from the University of Buenos Aires, a MBA from the UNED of Madrid and Executive Leadership Certification from MIT Sloan.
Julio C. Vega, Ph.D., Vice President of R&D at Amcyte Pharma since 2019, has worked on the pharmaceutical development of drugs, including biologic products, for more than 30 years, developing products marketed today in Europe, the US, Canada, Asia and Latin America. Dr. Vega is the author and co-author of patents related to pharmaceutical formulations, biopharmaceuticals and pharmaceutical primary packaging materials. He also authored of multiple pharmaceutical formulations for biopharmaceuticals and small molecule pharmaceuticals. He holds a Master in Chemistry from the University of Buenos Aires, a Master of Industrial Business Administration from Escuela de Organización Industrial de Madrid and a postgraduate degree in Industrial Business Administration from Universidad Católica Argentina.